Results 211 to 220 of about 43,958,210 (312)
The Observation of Solar Granulation from A Manned Balloon: I. OBSERVATIONAL DATA AND MEASUREMENT OF CONTRAST [PDF]
D. E. Blackwell+2 more
openalex +1 more source
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit+19 more
wiley +1 more source
The Time Has Come: Indigenous Peoples Worldwide Must Now Exercise Their Human Rights and Take Full Control Over Their Data Sovereignty Rights. [PDF]
Stuart L, Howell N.
europepmc +1 more source
Simple Equation for Estimating the Dipole Moment of a Molecule from Solution Data [PDF]
Satish C. Srivastava, P. Charandas
openalex +1 more source
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain+3 more
wiley +1 more source
Understanding alcohol use around water: A qualitative analysis of the experiences of young males. [PDF]
Sas SV+4 more
europepmc +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
Accurate MRF-Based 3D Multi-Channel B<sub>1</sub> <sup>+</sup> Mapping in the Human Body at 7 T. [PDF]
Lutz M+5 more
europepmc +1 more source
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source